HomeMBIO • NASDAQ
add
Mustang Bio Inc
Nakaraang pagsara
$1.09
Sakop ng araw
$1.04 - $1.13
Sakop ng taon
$1.01 - $65.00
Market cap
3.70M USD
Average na Volume
723.41K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | -26.00K | -100.29% |
Net na kita | -952.00K | 88.95% |
Net profit margin | — | — |
Kita sa bawat share | 3.63 | 110.22% |
EBITDA | 77.00K | 100.90% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 6.84M | 9.70% |
Kabuuang asset | 9.31M | -47.54% |
Kabuuang sagutin | 13.18M | -25.19% |
Kabuuang equity | -3.87M | — |
Natitirang share | 3.30M | — |
Presyo para makapag-book | -0.51 | — |
Return on assets | 0.79% | — |
Return on capital | -1.22% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -952.00K | 88.95% |
Cash mula sa mga operasyon | -2.00M | 72.47% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 4.94M | 24.77% |
Net change in cash | 2.94M | 188.31% |
Malayang cash flow | -1.54M | 68.98% |
Tungkol
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
Itinatag
2015
Headquarters
Website
Mga Empleyado
6
